39 completed, 9 terminated, 3 recruiting, 3 unknown. 19 Phase 2, 12 Phase 1, 9 Phase 3, 8 Phase 4, 4 Not applicable.
Follow riociguat: new trials by email Literature Review of riociguat trials Research Report on riociguat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Riociguat-Discontinue Effects on Right HEART in CTEPH (RED-HEART) Riociguat, Routine Treatment - Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Recruiting | Suqiao Yang | 68 | 2025-03-21 | 2025-04-30 |
| Effects of Combination Medical Therapy Followed by BPA on Right Ventricular-PA Coupling and Hemodynamics in CTEPH Macitentan Tablets, Riociguat, balloon pulmonary angioplasty - CTEPH | Phase 3 | Terminated | Dr Sudarshan Rajagopal | 7 | 2025-01-27 | 2026-09-03 |
| Switching of Sildenafil to Riociguat in CTEPH Patients Riociguat (Adempas) - Chronic Thromboembolic Pulmonary Hypertension | Phase 4 | Recruiting | Chinese University of Hong Kong | 30 | 2024-07-25 | 2025-05-29 |
| Pulmonary Hypertension: Intensification and Personalisation of Combination Rx Selexipag, Riociguat, CardioMEMS pulmonary artery pressure monitor - Pulmonary Arterial Hypertension | Phase 4 | Active not recruiting | Sheffield Teaching Hospitals NHS Foundation Trust | 70 | 2023-06-14 | 2026-08-07 |
| Effect of Riocigaut on Migraine Attack Induction in People With Migraine Riociguat (BAY 63-2521), Placebo - Migraine Without Aura | Not applicable | Completed | Danish Headache Center | 22 | 2023-06-01 | 2024-07-12 |
| Bioequivalence Study of Riociguat 2.5 mg Film Coated Tablets and Adempas (Riociguat) 2.5 mg Film Coated Tablets Riociguat film coated tablets, Adempas Filmtabletten - Pulmonary Arterial Hypertension | Phase 1 | Completed | Humanis Saglık Anonim Sirketi | 36 | 2023-03-07 | 2023-12-28 |
| Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy Volunteers Dose Riociguat 2,5 or 5mg, Riociguat, Placebo - Headache | Not applicable | Completed | Danish Headache Center | 15 | 2022-10-26 | 2024-01-05 |
| Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH Riociguat Oral Tablet, Placebo - Pulmonary Vascular Disorder, Primary Pulmonary Hypertension | Phase 2 | Terminated | Heidelberg University | 35 | 2022-10-24 | 2026-01-21 |
| Networked Drug REpurposing for Mechanism-based neuroPrOtection in Acute Ischaemic STROKE Riociguat, Propylthiouracil, Perphenazine - Ischemic Stroke, Acute | Phase 2 | Unknown | Maastricht University | 28 | 2022-09-05 | 2023-10-19 |
| Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH Riociguat - Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | Phase 4 | Terminated | Heidelberg University | 30 | 2022-04-13 | 2026-06-17 |
| A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) Riociguat (Adempas, BAY63-2521) - Pulmonary Arterial Hypertension | Completed | Bayer | 500 | 2021-07-16 | 2025-02-10 | |
| Possible Effects of Propylthiouracil, Riociguat and Perphenazine on Circulation of Healthy Volunteers Propylthiouracil, Riociguat, Perphenazine - Drug Drug Interaction, Safety Issues | Phase 1 | Completed | Maastricht University | 8 | 2021-03-18 | 2022-04-04 |
| THERAPY-HYBRID-BPA Trial Riociguat Oral Tablet - Hypertension, Pulmonary | Phase 2 | Unknown | National Hospital Organization Okayama Medical Center | 72 | 2020-10-16 | 2020-10-23 |
| A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants Macitentan, Sildenafil, Riociguat - Healthy | Phase 1 | Completed | Actelion | 47 | 2020-01-14 | 2025-03-30 |
| Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH Treprostinil Injectable Product, Riociguat Pill - Pulmonary Arterial Hypertension | Phase 3 | Recruiting | University of Arizona | 20 | 2019-03-25 | 2025-02-20 |
| Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study) Riociguat, Placebo, Pulmonary endarterectomy - Chronic Thromboembolic Pulmonary Hypertension, CTEPH | Phase 2 | Terminated | International CTEPH Association | 14 | 2018-08-17 | 2021-06-22 |
| Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty Adempas - Chronic Thromboembolic Disease (CTED), Exercise Intolerance Post PEA Surgery | Phase 2 | Completed | University of Colorado, Denver | 10 | 2018-06-13 | 2026-02-05 |
| Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics Riociguat (Adempas), Macitentan (Opsumit) - Healthy Subjects | Phase 1 | Completed | Actelion | 20 | 2018-01-09 | 2018-02-08 |
| A Multi-Center Study of Riociguat in Patients With Sickle Cell Diseases Riociguat, Placebo - Sickle Cell Disease | Phase 2 | Completed | Mark Gladwin | 130 | 2017-04-11 | 2023-07-19 |
| Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension Riociguat, Pulmonary Endarteriectomy, Ballon Pulmonary Angioplasty - Chronic Thromboembolic Pulmonary Hypertension, Sleep Disordered Breathing | Not applicable | Completed | Medical University of Vienna | 50 | 2017-02-01 | 2023-03-14 |
Showing 20 of 58. Sign in to see all of them.
Hypertension, Pulmonary (25) · Pulmonary Arterial Hypertension (12) · Ventricular Dysfunction, Left (3) · Headache (2) · Scleroderma, Systemic (2) · Altitude Sickness (1) · Anemia, Sickle Cell (1) · Coronary Artery Disease (1) · Cystic Fibrosis (1) · Familial Primary Pulmonary Hypertension (1) · Hypertension (1) · Idiopathic Interstitial Pneumonias (1) · Ischemic Stroke (1) · Limb-girdle muscular dystrophy, type 2E (1) · Migraine Disorders (1)
Bayer (34) · Actelion (2) · Danish Headache Center (2) · Heidelberg University (2) · Maastricht University (2) · Medical University of Vienna (2) · Assistance Publique - Hôpitaux de Paris (1) · Chinese University of Hong Kong (1) · Dinesh Khanna, MD, MS (1) · Dr Sudarshan Rajagopal (1) · Humanis Saglık Anonim Sirketi (1) · International CTEPH Association (1) · Mark Gladwin (1) · National Hospital Organization Okayama Medical Center (1) · Richard Moon (1)
Germany (32) · United States (25) · France (16) · United Kingdom (16) · Belgium (14) · Italy (14) · Japan (14) · Austria (13) · Canada (13) · Czechia (12) · Denmark (11) · Switzerland (11) · Turkey (Türkiye) (11) · Spain (9) · Australia (8)
Alexander Rothman, MD / PhD (1) · David Jenkins, MD (1) · Diana Bonderman, MD (1) · Dinesh Khanna, MD (1) · Franz Rischard, DO (1) · Irene Lang, Prof. (1) · Johannes Kastner, MD (1) · Mark Gladwin, MD (1) · Messoud Ashina, MD (1) · Messoud B Ashina, MD, Phd, DMSc (1) · Peter Sottile, MD (1)
PMID 27162632, PMID 27263466, PMID 34353714, PMID 23883377, PMID 23883378, PMID 23883383, PMID 26135803, PMID 27067478, PMID 27326239, PMID 27457511, PMID 34848133, PMID 35256218, PMID 19705340, PMID 20530034, PMID 22719060, PMID 22936711, PMID 23775260, PMID 24991733, PMID 25614164, PMID 25657022, PMID 26910470, PMID 27067479, PMID 27106231, PMID 27887774, PMID 27890471, PMID 28011757, PMID 28610669, PMID 28889107, PMID 29282032, PMID 31416769, PMID 31481106, PMID 32754307, PMID 33773120, PMID 34224432, PMID 34363816, PMID 34419414, PMID 34889382, PMID 35926542, PMID 37407055, PMID 38251533, PMID 38460548, PMID 38554715, PMID 39965044, PMID 40371623, PMID 40714010, PMID 41484960, PMID 42023995, PMID 42457022, PMID 42538528
2008 (5), 2014 (4), 2009 (3), 2016 (2), 2019 (2), 2023 (2), 2017 (1)